Antipsychotic drug administration differentially affects [3H]muscimol and [3H]flunitrazepam GABAA receptor binding sites

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 2, 2008, Pages 492-498

  Skilbeck, Kelly J ^a,b   O'Reilly, Jennifer N ^a,b   Johnston, Graham A R ^a,b   Hinton, Tina ^a,b  

^a University of Sydney   (Australia)

^b Schizophrenia Research Institute   (Australia)

Author keywords

Antipsychotic drug; Autoradiography; GABAA receptor; Haloperidol; Olanzapine; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE DERIVATIVE; FLUNITRAZEPAM; HALOPERIDOL; MUSCIMOL; NEUROLEPTIC AGENT; OLANZAPINE; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; CONTROLLED STUDY; DRUG MECHANISM; HIPPOCAMPUS; MALE; NONHUMAN; PREFRONTAL CORTEX; RAT; SCHIZOPHRENIA; THALAMUS;

ANIMALS; ANTIPSYCHOTIC AGENTS; AUTORADIOGRAPHY; BENZODIAZEPINES; DENSITOMETRY; FLUNITRAZEPAM; HALOPERIDOL; HIPPOCAMPUS; HUMANS; MALE; MUSCIMOL; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SCHIZOPHRENIA; THALAMUS; TISSUE DISTRIBUTION; TRITIUM;

EID: 38849207889     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.10.003     Document Type: Article

References (39)

1. Aravagiri M., Yaroslav T., and Marder S.R. Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharm Drug Dispos 20 (1999) 369-377
2. Asproni B., Pau A., Bitti M., Melosu M., Cerri R., Dazzi L., et al. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors. J Med Chem 45 (2002) 4655-4668
3. Barbaccia M.L., Affricano D., Purdy R.H., Maciocco E., Spiga F., and Biggio G. Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat. Neuropsychopharmacology 25 (2001) 489-497
4. Benes F.M. The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia. J Psychiatr Res 31 (1997) 257-275
5. Benes F.M., Khan Y., Vincent S.L., and Wickramasinghe R. Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain. Synapse 22 (1996) 338-349
6. A receptor binding on neurons of prefrontal cortex in schizophrenic subjects. Neuroscience 12 (1996) 1021-1031
7. Chebib M., and Johnston G.A. GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology. J Med Chem 43 (2000) 1427-1447
8. A receptors in rat striatum. Life Sci 69 (2001) 1257-1268
9. Deng C., and Huang X.-F. Increased density of GABAA receptors in the superior temporal gyrus in schizophrenia. Exp Brain Res 168 (2006) 587-590
10. Ebert B., Wafford K.A., Whiting P., Krogsgaard-Larsen P., and Kemp J.A. Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta and gamma receptor subunit combinations. Mol Pharmacol 46 (1994) 957-963
11. A receptors. Eur J Pharmacol 349 (1998) R7-R8
12. Fuchs V., Coper H., Strauss S., and Rommelspacher H. Diazepam attenuates the antagonism of haloperidol against apomorphine-induced stereotypic behavior after subchronic but not acute treatment in rats. Naunyn-Schmiedeberg's Arch Pharmacol 334 (1986) 133-137
13. Gavish M., Weizman R., Becker D., and Tanne Z. Effect of chronic haloperidol treatment on peripheral benzodiazepine binding sites in cerebral cortex of rats. J Neural Transm 74 (1988) 109-116
14. 3H] Muscimol binding sites increased in autopsied brains of chronic schizophrenics. Life Sci 40 (1987) 259-266
15. Janssen P.A. The evolution of the butyrophenones, haloperidol and trifluperidol, from meperidine-like 4-phenylpiperidines. Int Rev Neurobiol 8 (1965) 221-263
16. Kapur S., Arenovich T., Agid O., Zipursky R., Lindborg S., and Jones B. Evidence for onset of antipsychotic effects within the first 24 h of treatment. [see comment]. Am J Psychiatry 162 (2005) 939-946
17. Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci 3 (2002) 102-114
18. Kiuchi Y., Kobayashi T., Takeuchi J., Shimizu H., Ogata H., and Toru M. Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics. Eur Arch Psychiatr Neurol Sci 239 (1989) 71-78
19. Korpi E.R., Wong G., and Luddens H. Subtype specificity of gamma-aminobutyric acid type A receptor antagonism by clozapine. Naunyn-Schmiedeberg's Arch Pharmacol 352 (1995) 365-373
20. A/benzodiazepine receptor complex. J Recept Res 11 (1991) 535-551
21. Marx C.E., Duncan G.E., Gilmore J.H., Lieberman J.A., and Morrow A.L. Olanzapine increases allopregnanolone in the rat cerebral cortex. Biol Psychiatry 47 (2000) 1000-1004
22. A-receptor subtypes really occur in the brain?. Trends in Neuroscience 19 (1996) 139-143
23. Michel F.J., and Trudeau L.E. Clozapine inhibits synaptic transmission at GABAergic synapses established by ventral tegmental area neurones in culture. Neuropharmacology 39 (2000) 1536-1543
24. Nechmad A., Maayan R., Ramadan E., Morad O., Poyurovsky M., and Weizman A. Clozapine decreases rat brain dehydroepiandrosterone and dehydroepiandrosterone sulfate levels. Eur Neuropsychopharmacol 13 (2003) 29-31
25. Palacios J.M., Wamsley J.K., Zarbin M.A., and Kuhar M.J. GABA and glycine receptors in rat brain: autoradiographic localization. Adv Biochem Psychopharmacol 29 (1981) 445-451
26. Pandey G.N., Conley R.R., Pandey S.C., Goel S., Roberts R.C., Tamminga C.A., et al. Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects. Psychiatry Res 71 (1997) 137-149
27. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1997), Academic Press Inc.
28. A receptor subunit for benzodiazepine pharmacology. Nature 338 (1989) 582-585
29. Reynolds G.P., and Stroud D. Hippocampal benzodiazepine receptors in schizophrenia. J Neural Transm 93 (1993) 151-155
30. Skilbeck K.J., O'Reilly J.O., Johnston G.A.R., and Hinton T. The effects of antipsychotic drugs on GABA-A receptor binding depend on period of drug treatment and binding site examined. Schizophr Res 90 (2007) 76-80
31. 3H] flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses?. Neurochem Res 18 (1993) 219-223
32. Squires R.F., and Saederup E. Clozapine and some other antipsychotic drugs may preferentially block the same subset of GABA(A) receptors. Neurochem Res 22 (1997) 151-162
33. Ugale R.R., Hirani K., Morelli M., and Chopde C.T. Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents. Neuropsychopharmacology 29 (2004) 1597-1609
34. Unwin N. The structure of ion channels in membranes of excitable cells. Neuron 3 (1989) 665-676
35. Volavka J., Cooper T., Czobor P., Bitter I., Meisner M., Laska E., et al. Haloperidol blood levels and clinical effects. Arch Gen Psychiatry 49 (1992) 354-361
36. A receptor subtypes in the brain: a paradigm for CNS drug discovery?. Drug Discov Today 8 (2003) 445-450
37. A receptors. Eur J Pharmacol 314 (1996) 319-323
38. Young W.S., and Kuhar M.J. Autoradiographic localization of benzodiazepine receptors in the brains of humans and animals. Nature 280 (1979) 393-395
39. 67 expression. Schizophr Res 66 (2004) 151-157